Endovascular Acute Ischemic Stroke Treatment: Analysis of the First 100 Cases

Yıl 2021, , 82 - 87, 28.04.2021

Özcan Kocatürk , Mehtap Kocatürk

https://doi.org/10.35440/hutfd.803058

Cited By: 1

Öz

Background: Stroke account for 15% of all deaths in Turkey. In acute ischemic stroke (AIS), neuronal damage continues every minute until the occluded vessel is not opened. Currently, the most important treatment of AIS is the rapid and effective opening of the occluded vessel. In this study, we aimed to share our experience of endovascular treatment of AIS patients in our center.
Materials and Methods: Between January 2015 - November 2018, the first 100 consecutive patients who presented with the diagnosis of AIS and received endovascular treatment were included in this study. We recorded the clinical and demographic characteristics and endovascular procedure characteristics of all patients.
Results: Of the 100 patients included in the study, 49 were female and 51 were male, and the median age was 65 (55-74). Hypertension was present in 74%, hyperlipidemia in 25%, diabetes mellitus in 38%, atrial fibrillation in 26%, coronary artery disease in 36%, and smoking in 39% patients. The Median NIHSS score was 15.5 (13-19) prior to treatment. At the 3-month follow-up, 31 patients died and the mortality rate was calculated as 31%. At the end of the 3-month, good outcome was observed in 40% of patients (modified Rankin scale score 0-2). Our effective recanalization rate (Thrombolysis in Cerebral Infarction [TICI2b-3]) was found to be 75%.
Conclusions: AIS patients with suspected large artery occlusion should be transferred to centers where endovascular treatment is available, as soon as possible. Better results can be achieved as experience of endovascular treatment in centers increases.

Endovasküler Akut İskemik İnme Tedavisi: İlk 100 Vakanın Analizi

Öz

Amaç: İnme, Türkiye’de tüm ölümlerin %15 nedenidir. Akut iskemik inmede(Aİİ) tıkanın damarın açılmadığı her dakikada nöron harabiyeti devam etmektedir ve bugün için Aİİ’nin erken dönem en önemli tedavisi tıkalı damarın hızlı ve etkili şekilde açılmasıdır. Biz bu çalışmada merkezimizdeki inme hastalarına uygulanan endovasküler tedavi deneyimlerimizi paylaşmayı amaçladık.

Materyal ve method: Ocak 2015 ve Kasım 2018 arasında başvuran, Aİİ tanısı konarak endovasküler tedavi alan ardışık ilk 100 hastanın klinik ve demografik özelliklerini ve endovasküler işlem özelliklerini kaydettik.

Bulgular: Çalışmaya dahil edilen 100 hastanın 49’u kadın, 51’i erkekti ve yaş ortalamaları 65(55-74) idi. Hastaların %74’ünde hipertansiyon, %25’inde hiperlipidemi, %38’inde diabetes mellitus, %26’sınde atrial fibrilasyon, %36’ünde koroner arter hastalığı ve %39’ünde sigara kullanımı mevcuttu. Hastaların tedavi öncesi National Institutes of Health Stroke Scale (NIHSS) skoru 15,5 (13-19) idi. Üç aylık takipte 31 hasta kaybedildi ve mortalite oranı %31 olarak hesaplandı. Üçüncü ay sonunda %40 hastada iyi sonuç gözlemlendi (modifiye Rankin skalası skoru 0-2). Etkili rekanalizasyon oranımızın [ Thrombolysis in Cerebral Infarction (TICI2b-3)] %75 olduğu görüldü.
Sonuç: Büyük arter tıkanıklığı düşünülen hastaların en erken dönemde endovasküler tedavi imkanlarının olduğu merkezlere sevki sağlanmalıdır. Merkezlerde endovasküler tedavi deneyimi artıkça daha iyi sonuçlar elde edilebilir.

Anahtar Kelimeler

Akut iskemik inme, Endovasküler tedavi, Mortalite

Kaynakça

• 1. LB. Goldstein. Ischemic cerebrovascular Disease, In: L. Goldman, A.I. Schafer(Eds) Goldman- Cecil Medicine 25th edition Elsevier Saunders, USA 2016, pp 2434-45.
• 2. Özkan E, Arsava EM, Topçuoğlu MA, Akut İnme ; Hasta değerlendirilmesi. Gökçe M, editör.İnme-1 Ankara: Türkiye Klinikleri; 2018 p.20-6.
• 3. Goyal M, Menon BK, van Zwam et al HERMES collaborators. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet 2016 Apr 23;387:1723-31.
• 4. Hacke W, Kaste M, Fieschi C, et al. Randomised double-blind placebocontrolled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 1998;352:1245-1251.
• 5. Zaidat OO, Yoo AJ, Khatri P, et al. Recommendations on Angiographic Revascularization Grading Standards for Acute Ischemic Stroke: A Consensus Statement. Stroke; a journal of cerebral circulation 2013;44:2650–63.
• 6. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase to 4•5 hours after acute ischemic stroke. N Engl J Med 2008;359: 1317–29
• 7. De Silva DA, Brekenfeld C, Ebinger M, et al. The benefits of intravenous thrombolysis related to the site of baseline arterial occlusion in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET). Stroke 2010; 41: 295–99.
• 8. Fischer U, Kaesmacher J, Mendes Pereira V, et al. Direct mechanical thrombectomy versus combined intravenous and mechanical thrombectomy in large-artery anterior circulation stroke: a topical review. Stroke 2017;48:2912–8.
• 9. Kaesmacher J, Mordasini P, Arnold M, et al. Direct mechanical thrombectomy in tPA-ineligible and -eligible patients versus the bridging approach: a meta-analysis. J Neurointerv Surg 2019 Jan;11:20-27.
• 10. Simonsen CZ, Yoo AJ, Sørensen LH, et al Effect of General Anesthesia and Conscious Sedation During Endovascular Therapy on Infarct Growth and Clinical Outcomes in Acute Ischemic Stroke: A Randomized Clinical Trial. JAMA Neurol 2018 Apr 1;75:470-477.
• 11. Nguyen TN, Malisch T, Castonguay AC, et al. Balloon guide catheter improves revascularization and clinical outcomes with the solitaire device: analysis of the North american solitaire acute stroke registry. Stroke 2014;45:141–145.
• 12. Powers WJ, Rabinstein AA, Ackerson T, et al; American Heart Association Stroke Council. 2018 Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2018;49:e46–e110.
• 13. Ducroux C, Piotin M, Gory B,et al; ASTER Trial investigators. First pass effect with contact aspiration and stent retrievers in the Aspiration versus Stent Retriever (ASTER) trial. J Neurointerv Surg 2019 Aug 30. pii: neurintsurg-2019-015215.
• 14. Zaidat OO, Castonguay AC, Linfante I, et al . First Pass Effect: A New Measure for Stroke Thrombectomy Devices. Stroke 2018 Mar;49:660-666.
• 15. Samaniego EA, Dabus G, Linfante I. Stenting in the treatment of acute ischemic stroke: literature review. Front Neurol 2011 Dec 9;2:76.
• 16. Hsieh KL, Chuang KI, Weng HH, Cheng SJ, Chiang Y, Chen CY. First-Line A Direct Aspiration First-Pass Technique vs. First-Line Stent Retriever for Acute Ischemic Stroke Therapy: A Meta-Analysis. Front Neurol 2018 Sep 25;9:801.